DNA StructureResearch ExplainedView more about Research Explained
Understand the different stages that are needed to develop a therapy and the many exciting approaches underway.
Research
Research content
Target 5000 logoTarget 5000View more about Target 5000
Target 5000 provides clinical and genotyping services for people living in Ireland with an inherited retinal degeneration.
Research NewsResearch NewsView more about Research News
The pace of research has never been so rapid. We aim to provide you the most up to date news on the advances as they happen.
Two smiling scientists in a labMeet your researchersView more about Meet your researchers
Get to know the scientists and clinicians who are leading the way into a new era of prevention, detection and treatment for sight loss conditions.
Patient involvement in Research and Advocacy (PPI)Patient involvement in Research and Advocacy (PPI)View more about Patient involvement in Research and Advocacy (PPI)
PPI is the working partnership between patients, clinicians, scientists, industry and regulators to advance research and access to therapies.
Information for ResearchersInformation for ResearchersView more about Information for Researchers
We are committed to driving the development of therapies and cures, which are accessible to all patients affected by sight loss and the wide spectrum of retinal degenerative disease.